POU5F1P4 and colorectal carcinoma: Peng et al. observed that POU class 5 Homeobox-1 pseudogene 4 (POU5F1P4) down-regulation reduces the sensitivity of metastatic CRC cells to cetuximab and could be a potential new treatment for metastatic CRC [88].